2Yanga Z, Zadjura L, Arienzo C, et al Predinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics[ J]. Biopharm Drug Dispos, 2005, 26 (9) : 387-402.
3Xue YJ, Yan JH, Arnold M, et al. Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry[ J]. J Sep Sci, 2007, 30 (9) : 1267-1275.
4Lin PF, Blair W, Wang T, et al. A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding [J]. Proc Natl Acad Sci USA, 2003, 100(19) : 11013-11018.
5Duong YT, Meadows DC, Sfivasta IK, et al. Direct inactivation of human immunodeficiency virus type 1 by a novel smaU-molecule entry inhibitor, DCM205 [J]. Antimicrob Agents Ch, 2007, 51 (5) : 1780-1786.
6Clercq ED. Antiviral drugs in current clinical use[J]. J Clin Virol, 2004, 30(2) : 115-133.
7Urata H, Kumashiro T, Kawahata T, et al. Anti-HIV-1 activity and mode of action of mirror image oligodeoxynucleofide analogue of zintevir[J] . Biochem Bioph Res Co, 2004, 313(1 ) : 55-61.
8Bell TW, Anugu S, Bailey P, et al. Synthesis and structure-activity relationship studies of CD4 down-modulating cyelotriazadisulfonamide (CADA) analogues[J]. J Med Chem, 2006, 49(4) : 1291-1312.
9Kuritzkes DR, Jacobson J, Powderly WG, et al. Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type l[J]. J Infect Dis, 2004, 189(2) : 286-291.
10Zhang XQ, Sorensen M, Fung M, et al. Synergistic in vitro antiretroviral activity of a humanized monoclonal anti-CD4 antibody ( TNX- 355) and enfuvirtide(T-20) [J]. Antimicrob Agents Ch, 2006, 50 (6) : 2231-2233.
3Zhang L,Yu W,He T,et al.Contribution of human alpha-defensin 1,2,and 3 to the anti-HIV-1 activity of CD8 antiviral factor[J].Science,2002,298 (5595):995-1000.
4Chang TL,Vargas J,DelPortillo A,et al.Dual role of alphadefensin-1 in anti-HIV-1 innate immunity[J].J Clin Invest,2005,115(3):765-773.
5Chang TL,Francois F,Mosian A,et al.CAF-mediated HIV type 1 transcriptional inhibition is distinctfrom alpha-defensin-1 HIV inhibition[J].J Virol,2003,77(12):6777-6784.
6Mackewicz C,Yuan J,Tran P,et al.Alpha-defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors[J].AIDS,2003,17(14):23-32.
